Breaking News Instant updates and real-time market news.

2022-12-01 16:17:56 ASAN Asana $18.07 / -0.09 (-0.50%) 16:17 12/01/22 12/01 16:17 12/01/22 16:17	Asana reports Q3 EPS (26c), consensus (32c) Reports Q3 revenue $141.4M, consensus $139.4M. "We reported a strong quarter with revenues up 41% year over year. The number of customers spending $100,000 or more grew 78%, year over year, and our largest deployment is now over 150,000 seats. Our success with large enterprises continues to drive growth," said Dustin Moskovitz, CEO of Asana. "While macroeconomic cross currents continue to impact the business in the near term, our leading technology and strong brand position us well in the enormous and untapped Work Management market over the long term. We will continue to actively manage the business to improve efficiencies while maintaining our leadership in product innovation."	01 Dec

2022-12-01 16:17:56

ASAN

Asana

$18.07 / -0.09 (-0.50%)

16:17

12/01/22

12/01

16:17

12/01/22

16:17

Asana reports Q3 EPS (26c), consensus (32c)

Reports Q3 revenue $141.4M, consensus $139.4M. "We reported a strong quarter with revenues up 41% year over year. The number of customers spending $100,000 or more grew 78%, year over year, and our largest deployment is now over 150,000 seats. Our success with large enterprises continues to drive growth," said Dustin Moskovitz, CEO of Asana. "While macroeconomic cross currents continue to impact the business in the near term, our leading technology and strong brand position us well in the enormous and untapped Work Management market over the long term. We will continue to actively manage the business to improve efficiencies while maintaining our leadership in product innovation."

01
Dec

OTHER BREAKING NEWS FROM THE FLY

Recommendations	iCAD price target lowered to $2.50 from $5 at Lake Street » 08:56 03/29/23 03/29 08:56 03/29/23 08:56 ICAD iCAD $1.21 / -0.08 (-6.20%) Lake Street lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ICAD iCAD $1.21 / -0.08 (-6.20%) 03/13/23 iCAD engages bankers to explore strategic options for Therapy business line 03/13/23 iCAD CEO Stacey Stevens resigns, Dana Brown named president, CEO 03/01/23 iCAD announces new real-world clinical evidence on ProFound AI 01/23/23 iCAD Pressure announces CFO transition, hires SVP, US commercial sales ICAD iCAD $1.21 / -0.08 (-6.20%) 07:28 Today BTIG iCAD price target lowered to $3 from $4 at BTIG 11/29/22 Lake Street Google Health partnership 'significant positive' for iCAD, says Lake Street 11/28/22 JMP Securities JMP views iCAD agreement with Google Health 'very favorably' 11/11/22 Lake Street iCAD price target lowered to $5 from $8 at Lake Street ICAD iCAD $1.21 / -0.08 (-6.20%) 03/28/23 iCAD reports Q4 EPS (12c), consensus (14c) 03/13/23 iCAD sees Q4 revenue $6.5M, consensus $6.61M ICAD iCAD $1.21 / -0.08 (-6.20%) 03/13/23 What You Missed On Wall Street On Monday 03/13/23 What You Missed On Wall Street This Morning
Hot Stocks	Omniq selected to deploy machine vision solution in the Middle East » 08:56 03/29/23 03/29 08:56 03/29/23 08:56 OMQS Omniq $4.09 / -0.21 (-4.88%) OMNIQ has been selected… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Events OMQS Omniq $4.09 / -0.21 (-4.88%) 03/13/23 Omniq Corp trading resumes 03/13/23 Omniq Corp trading halted, volatility trading pause 03/08/23 Omniq announces orders for AI-based parking, security solution 02/21/23 Omniq AI-based machine vision safe city system to be deployed in Georgia 03/31/23 Omniq - OMQS
Initiation	Stryker initiated with a Neutral at UBS » 08:55 03/29/23 03/29 08:55 03/29/23 08:55 SYK Stryker $277.38 / -0.62 (-0.22%) UBS analyst Danielle… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options SYK Stryker $277.38 / -0.62 (-0.22%) 02/17/23 Stryker's Q Guidance System for cranial applications receives FDA clearance 02/13/23 Stryker exec Menon sells 2,161 common shares 02/06/23 Stryker CFO Boehnlein sells $6.8M in common stock 12/07/22 Stryker raises quarterly dividend 7.9% to 7.5c per share SYK Stryker $277.38 / -0.62 (-0.22%) 03/28/23 UBS Stryker initiated with a Neutral at UBS 02/21/23 Argus Stryker price target raised to $285 from $270 at Argus 02/02/23 Barclays Stryker price target raised to $283 from $265 at Barclays 02/01/23 Loop Capital Stryker price target raised to $290 from $245 at Loop Capital SYK Stryker $277.38 / -0.62 (-0.22%) 01/31/23 Stryker sees FY23 adjusted EPS $9.85-$10.15, consensus $9.86 01/31/23 Stryker reports Q4 adjusted EPS $3.00, consensus $2.84 10/31/22 Stryker reports Q3 adjusted EPS $2.12, consensus $2.23 10/31/22 Notable companies reporting after market close SYK Stryker $277.38 / -0.62 (-0.22%) 02/01/23 Fly Intel: Pre-market Movers 01/31/23 Fly Intel: After-Hours Movers 01/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/01/22 What You Missed On Wall Street On Tuesday 05/10/23 Stryker Corp. SYK Stryker $277.38 / -0.62 (-0.22%) 02/01/23 Early notable gainers among liquid option names on February 1st 01/31/23 Stryker options imply 2.7% move in share price post-earnings 10/31/22 Stryker options imply 3.8% move in share price post-earnings
Hot Stocks	Gain Therapeutics presents preclinical data from GBA1 Program » 08:55 03/29/23 03/29 08:55 03/29/23 08:55 GANX Gain Therapeutics $4.70 / -0.055 (-1.16%) Gain Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events GANX Gain Therapeutics $4.70 / -0.055 (-1.16%) 03/23/23 Gain sees dossier submission for Phase 1 clinical trial of GT-0228 by mid 2023 03/23/23 Gain Therapeutics sees completion of IND enabling studies of GT-02287 in 1H 2023 03/21/23 Gain Therapeutics announces grant award by Eurostars with Innosuisse 02/27/23 Gain Therapeutics presents preclinical data from Gaucher Disease Program GANX Gain Therapeutics $4.70 / -0.055 (-1.16%) 03/27/23 Chardan Gain Therapeutics price target raised to $5.75 from $4 at Chardan 12/09/22 Chardan Gain Therapeutics initiated with a Buy at Chardan 11/25/22 Oppenheimer Gain Therapeutics price target lowered to $10 from $30 at Oppenheimer 11/14/22 H.C. Wainwright Gain Therapeutics price target lowered to $10 from $12 at H.C. Wainwright GANX Gain Therapeutics $4.70 / -0.055 (-1.16%) 03/23/23 Gain Therapeutics reports FY22 EPS ($1.48), consensus ($1.51) 11/10/22 Gain Therapeutics reports Q3 EPS (38c), consensus (46c) 00:00 Today Biotechnology
Options	Notable open interest changes for March 29th » 08:55 03/29/23 03/29 08:55 03/29/23 08:55 BABA Alibaba $98.41 / +12.28 (+14.26%) , AMC AMC Entertainment $5.13 / +0.56 (+12.27%) , TSLA Tesla $189.18 / -2.67 (-1.39%) , AMZN Amazon.com $97.27 / -0.84 (-0.86%) Tuesday's total… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BABA AMC TSLA AMZN BABA Alibaba $98.41 / +12.28 (+14.26%) 03/28/23 Alibaba rises 12.4% 03/28/23 Alibaba to reorganize into six business groups and other investments 02/23/23 Alibaba jumps 6% to $100.65 after Q3 results beat estimates 02/23/23 Alibaba CEO sees 'continued recovery in consumer sentiment' AMC AMC Entertainment $5.13 / +0.56 (+12.27%) 03/14/23 CEO says AMC 'APE' conversion approved by shareholders 03/14/23 AMC falls after investors approve increase in common shares 03/14/23 AMC Entertainment trading resumes 03/14/23 AMC shares fall 10% amid shareholder votes at special meeting TSLA Tesla $189.18 / -2.67 (-1.39%) 03/28/23 NHTSA probing 50,000 Tesla Model Xs over seat belt malfunction 03/26/23 Fly Intel: Top five weekend stock stories 03/23/23 Cathie Wood's ARK Investment sold 140K shares of Tesla today 03/21/23 EU passenger car registrations up 11.5% in February AMZN Amazon.com $97.27 / -0.84 (-0.86%) 03/28/23 Google teams with AI firm Replit to aid generative AI for software development 03/28/23 Semtech announces first LoRa-enabled third party products available 03/28/23 Lifeist's Mikra debuts on Amazon.com 03/24/23 User reports indicate problems at Amazon says Downdetector BABA AMC TSLA AMZN BABA Alibaba $98.41 / +12.28 (+14.26%) 07:17 Today Loop Capital Alibaba shares offer event-driven upside, says Loop Capital 05:57 Today JPMorgan JPMorgan 'blue sky scenario' has Alibaba worth $210 per share 03/28/23 Truist Truist sees Alibaba reorganization driving accountability, shareholder value 03/28/23 Morgan Stanley Alibaba named 'Research Tactical Idea' at Morgan Stanley AMC AMC Entertainment $5.13 / +0.56 (+12.27%) 07:52 Today Wedbush Amazon unlikely to acquire AMC, says Wedbush 03/28/23 Raymond James EPR has upside if AMC were to be sold, says Raymond James 03/23/23 Citi AMC Entertainment resumed with a Sell at Citi 02/09/23 Macquarie Macquarie raises price target on top theatre pick for 2023 TSLA Tesla $189.18 / -2.67 (-1.39%) 03/28/23 Deutsche Bank Tesla estimates lowered after price cuts at Deutsche Bank 03/27/23 Morgan Stanley Morgan Stanley says Tesla 20% auto gross margin may prove difficult beyond Q1 03/27/23 Citi Tesla price target raised to $192 from $146 at Citi 03/27/23 Barclays Tesla delivery beat in Q1 could be share catalyst, says Barclays AMZN Amazon.com $97.27 / -0.84 (-0.86%) 07:52 Today Wedbush Amazon unlikely to acquire AMC, says Wedbush 06:46 Today KeyBanc Microsoft price target raised to $316 from $270 at KeyBanc 03/28/23 Raymond James EPR has upside if AMC were to be sold, says Raymond James 03/24/23 Barclays Meta Platforms price target raised to $270 from $260 at Barclays BABA AMC TSLA AMZN BABA Alibaba $98.41 / +12.28 (+14.26%) 02/23/23 Alibaba reports Q3 adjusted EPS $2.79, consensus $2.37 02/22/23 Notable companies reporting before tomorrow's open 02/22/23 Notable companies reporting before tomorrow's open 11/17/22 Alibaba reports Q2 adjusted EPS $1.82, consensus $1.64 AMC AMC Entertainment $5.13 / +0.56 (+12.27%) 02/28/23 AMC Entertainment reports Q4 adjusted EPS (14c), consensus (21c) 02/28/23 Notable companies reporting after market close 11/08/22 AMC Entertainment reports Q3 adjusted EPS (20c), consensus (25c) TSLA Tesla $189.18 / -2.67 (-1.39%) 03/02/23 Aehr Test Systems reiterates annual guidance, comments on Tesla statements 01/25/23 Tesla reports Q4 EPS $1.19, consensus $1.13 01/25/23 Notable companies reporting after market close 10/19/22 Tesla reports Q3 EPS $1.05, consensus 99c AMZN Amazon.com $97.27 / -0.84 (-0.86%) 02/02/23 Amazon sees Q1 revenue $121B-$126B, consensus $125.11B 02/02/23 Amazon reports Q4 EPS 3c with Rivian loss, consensus 17c 02/02/23 Notable companies reporting after market close 10/27/22 Amazon sees Q4 revenue $140B-$148B, consensus $155.15B BABA AMC TSLA AMZN BABA Alibaba $98.41 / +12.28 (+14.26%) 05:50 Today Alibaba reorganization triggers mass layoff fears, Nikkei Asia reports 03/28/23 Alibaba plans to split into six main units, explore IPOs, Bloomberg reports 03/27/23 Alibaba founder Jack Ma returns to China, Reuters reports 03/22/23 Part of Alibaba shareholder lawsuit dismissed by judge, Reuters reports AMC AMC Entertainment $5.13 / +0.56 (+12.27%) 03/28/23 Amazon has 'NO deal on the table' for AMC Entertainment, FBN says 03/28/23 AMC Entertainment up after blog post speculation on Amazon interest 03/14/23 AMC shareholders approve 1-for-10 stock split, Bloomberg reports 03/14/23 AMC holders approve increase to common shares, Bloomberg reports TSLA Tesla $189.18 / -2.67 (-1.39%) 03/28/23 Second-hand Tesla cars losing value faster following price cuts, FT reports 03/23/23 Canada budget to include tax credit for EV production equipment, Reuters says 03/23/23 Tesla sees losing $7,500 federal tax credit on Model 3 SR, Electrek reports 03/21/23 Grizzly Research reports short opinion on Sigma Lithium AMZN Amazon.com $97.27 / -0.84 (-0.86%) 03/28/23 Amazon, Google will have to let U.K. radio stream on smart speakers, FT says 03/28/23 Amazon has 'NO deal on the table' for AMC Entertainment, FBN says 03/28/23 AMC Entertainment up after blog post speculation on Amazon interest 03/28/23 Disney eliminates metaverse unit, cutting 50 jobs, WSJ reports BABA AMC TSLA AMZN BABA Alibaba $98.41 / +12.28 (+14.26%) 03/28/23 What You Missed On Wall Street On Tuesday 03/28/23 What You Missed On Wall Street This Morning 03/28/23 Fly Intel: Pre-market Movers 03/27/23 What You Missed On Wall Street This Morning AMC AMC Entertainment $5.13 / +0.56 (+12.27%) 03/28/23 What You Missed On Wall Street On Tuesday 03/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/28/23 Fly Intel: After-Hours Movers 12/28/22 What You Missed On Wall Street This Morning TSLA Tesla $189.18 / -2.67 (-1.39%) 03/28/23 What You Missed On Wall Street This Morning 03/27/23 What You Missed This Week in EVs and Clean Energy 03/26/23 Opening Day: Singapore's Ohmyhome makes Nasdaq debut 03/23/23 What You Missed On Wall Street On Thursday AMZN Amazon.com $97.27 / -0.84 (-0.86%) 03/28/23 What You Missed On Wall Street On Tuesday 03/26/23 Box Office Battle: ‘John Wick: Chapter 4’ opens with huge $73.5M 03/20/23 What You Missed On Wall Street On Monday 03/20/23 What You Missed On Wall Street This Morning 03/30/23 Enterprise IT BABA AMC TSLA AMZN BABA Alibaba $98.41 / +12.28 (+14.26%) 08:00 Today Alibaba call buyer realizes 50% same-day gains 03/28/23 Unusually active option classes on open March 28th 03/24/23 Alibaba call volume above normal and directionally bullish 03/24/23 Unusually active option classes on open March 24th AMC AMC Entertainment $5.13 / +0.56 (+12.27%) 03/28/23 AMC Entertainment call volume above normal and directionally bullish 03/15/23 Notable open interest changes for March 15th 03/14/23 Largest borrow rate increases among liquid names 03/06/23 Largest borrow rate increases among liquid names TSLA Tesla $189.18 / -2.67 (-1.39%) 03/28/23 Notable open interest changes for March 28th 03/24/23 Notable open interest changes for March 24th 03/23/23 Notable open interest changes for March 23rd 03/23/23 Tesla put buyer realizes 137% same-day gains AMZN Amazon.com $97.27 / -0.84 (-0.86%) 03/28/23 Notable open interest changes for March 28th 03/22/23 Notable open interest changes for March 22nd 03/07/23 Notable open interest changes for March 7th 03/03/23 Notable open interest changes for March 3rd
Hot Stocks	Biogen says BIIB080 'substantially reduced' tau protein level in early-stage AD » 08:54 03/29/23 03/29 08:54 03/29/23 08:54 BIIB Biogen $270.29 / +0.66 (+0.24%) Biogen reported Phase 1b… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BIIB Biogen $270.29 / +0.66 (+0.24%) 08:49 Today Ionis Pharmaceuticals' IONIS-MAPTRx shows tau reduction efficacy in Alzheimer's 03/22/23 Biogen provides update on AdCom meeting on Tofersen for SOD1-ALS 03/22/23 Inozyme appoints Matthew Winton as COO 03/20/23 FDA posts briefing document for advisors' review of Biogen's ALS drug BIIB Biogen $270.29 / +0.66 (+0.24%) 03/21/23 BofA FDA briefing docs suggest FDA in favor of Biogen's tofersen, says BofA 03/17/23 Stifel Stifel trims Biogen target, but has more confidence lecanemab 'best-in-class' 03/13/23 RBC Capital Biogen price target raised to $350 from $335 at RBC Capital 03/09/23 BofA No ad com suggests positive potential outcome for Sage's zura, says BofA BIIB Biogen $270.29 / +0.66 (+0.24%) 02/15/23 Biogen sees FY23 EPS $15.00-$16.00, consensus $15.72 02/15/23 Biogen reports Q4 EPS $4.05, consensus $3.48 02/14/23 Notable companies reporting before tomorrow's open 02/14/23 Notable companies reporting before tomorrow's open BIIB Biogen $270.29 / +0.66 (+0.24%) 03/13/23 VA to widely cover new Alzheimer's treatment from Eisai and Biogen, STAT says 01/11/23 FDA Commissioner defends FDA's approval of Biogen's Aduhelm, WSJ reports 12/23/22 Third trial death tied to Biogen and Eisai Alzheimer's drug, Science reports 11/28/22 Second death linked to Eisai's lecanemab Alzheimer's drug, Science says BIIB Biogen $270.29 / +0.66 (+0.24%) 02/15/23 What You Missed On Wall Street On Wednesday 02/15/23 What You Missed On Wall Street This Morning 02/15/23 Fly Intel: Pre-market Movers 01/20/23 Fly Intel: Pre-market Movers 07/06/23 PDUFA Date for Leqembi 08/05/23 PDUFA Date for Zuranolone 05/04/23 Biogen BIIB Biogen $270.29 / +0.66 (+0.24%) 11/30/22 Early notable gainers among liquid option names on November 30th 11/14/22 Early notable gainers among liquid option names on November 14th 10/13/22 Early notable gainers among liquid option names on October 13th 09/29/22 Unusually active option classes on open September 29th
Initiation	Baxter initiated with a Neutral at UBS » 08:53 03/29/23 03/29 08:53 03/29/23 08:53 BAX Baxter $39.86 / -0.215 (-0.54%) UBS analyst Danielle… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BAX Baxter $39.86 / -0.215 (-0.54%) 03/09/23 Baxter treatment of short bowel syndrome granted FDA orphan designation 02/09/23 Baxter falls -13.6% 02/09/23 Baxter falls -10.1% 02/01/23 Miromatrix Medical, Baxter enter research agreement for ALF BAX Baxter $39.86 / -0.215 (-0.54%) 03/28/23 UBS Baxter initiated with a Neutral at UBS 02/13/23 Barclays Baxter price target lowered to $54 from $63 at Barclays 02/10/23 Cowen Baxter price target lowered to $45 from $70 at Cowen 02/06/23 KeyBanc Baxter price target lowered to $60 from $73 at KeyBanc BAX Baxter $39.86 / -0.215 (-0.54%) 02/09/23 Baxter sees FY23 adjusted EPS $2.75-$2,95, consensus $3.56 02/09/23 Baxter sees Q1 adjusted EPS 46c-50c, consensus 76c 02/09/23 Baxter reports Q4 adjusted EPS 88c, consensus 94c 02/08/23 Notable companies reporting before tomorrow's open BAX Baxter $39.86 / -0.215 (-0.54%) 03/20/23 Thermo Fisher, Celltrion compete for Baxter's biopharma unit, Reuters says BAX Baxter $39.86 / -0.215 (-0.54%) 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 02/09/23 Fly Intel: Pre-market Movers 01/06/23 What You Missed On Wall Street On Friday 05/02/23 Baxter International Inc. BAX Baxter $39.86 / -0.215 (-0.54%) 02/21/23 Baxter call volume above normal and directionally bullish 02/09/23 Baxter put volume heavy and directionally bearish 01/24/23 Baxter put volume heavy and directionally bearish 01/05/23 Baxter call volume above normal and directionally bullish
Initiation	Johnson & Johnson assumed with a Neutral at UBS » 08:51 03/29/23 03/29 08:51 03/29/23 08:51 JNJ Johnson & Johnson $151.81 / -1.45 (-0.95%) UBS assumed coverage of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $151.81 / -1.45 (-0.95%) 07:10 Today STAAR Surgical names Warren Foust COO, Magda Michna, as chief of medical affairs 03/22/23 Johnson & Johnson issues statement on Third Circuit review petition 03/15/23 Janssen announces publication of data on dengue antiviral candidate 03/07/23 Protagonist Therapeutics reports 'positive' results from FRONTIER 1 Phase 2b JNJ Johnson & Johnson $151.81 / -1.45 (-0.95%) 03/28/23 UBS Johnson & Johnson initiated with a Neutral at UBS 03/13/23 Stifel Arcellx initiated with a Buy at Stifel 03/01/23 Guggenheim Johnson & Johnson initiated with a Neutral, $161 price target at Guggenheim 02/28/23 Guggenheim Johnson & Johnson initiated with a Neutral at Guggenheim JNJ Johnson & Johnson $151.81 / -1.45 (-0.95%) 02/28/23 Fate Therapeutics reports Q4 EPS (58c), consensus (86c) 01/30/23 Johnson & Johnson to challenge federal appeals court ruling 01/24/23 Johnson & Johnson sees FY23 adjusted EPS $10.45- $10.65, consensus $10.33 01/24/23 Johnson & Johnson sees FY23 adjusted operational EPS $10.40-$10.60 JNJ Johnson & Johnson $151.81 / -1.45 (-0.95%) 02/01/23 Novavax refuses to refund $700M for COVID shots never delivered, NY Times says 01/30/23 Appeals court dismisses Chapter 11 case of J&J unit, WSJ reports 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports 01/09/23 J&J may look for deals that boost eye care, surgical robots units, Reuters says JNJ Johnson & Johnson $151.81 / -1.45 (-0.95%) 03/01/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 01/24/23 What You Missed On Wall Street On Tuesday 04/18/23 Johnson & Johnson - JNJ 04/25/23 Johnson & Johnson 04/27/23 Johnson & Johnson JNJ Johnson & Johnson $151.81 / -1.45 (-0.95%) 03/22/23 Johnson & Johnson put volume heavy and directionally bearish 03/13/23 Unusually active option classes on open March 13th 01/31/23 Johnson & Johnson put buyer realizes 135% same-day gains 01/30/23 Johnson & Johnson put volume heavy and directionally bearish
Hot Stocks	United Health Products reports anomalies from lab testing of HemoStyp samples » 08:50 03/29/23 03/29 08:50 03/29/23 08:50 UEEC United Health Products / + United Health Products… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News UEEC United Health Products / + 01/31/23 UHP provides update on FDA PMA application, White Lion agreement 12/19/22 United Health Products provides update on PMA application 11/28/22 United Health to submit full PMA application following sample analysis review 10/31/22 United Health Products provides update on PMA application
Initiation	Abbott assumed with a Buy at UBS » 08:49 03/29/23 03/29 08:49 03/29/23 08:49 ABT Abbott $97.10 / -1.345 (-1.37%) UBS analyst Danielle… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ABT Abbott $97.10 / -1.345 (-1.37%) 03/07/23 Abbott: FDA clears first first commercially available TBI blood test 03/06/23 DexCom down more than 7% after FDA gives nod to Abbott CGM sensors 03/06/23 Abbott: FDA clears FreeStyle Libre 2, FreeStyle Libre 3 sensors 03/05/23 Abbott announces late-breaking data from landmark COAPT trial ABT Abbott $97.10 / -1.345 (-1.37%) 03/28/23 UBS Abbott initiated with a Buy at UBS 03/08/23 Jefferies DexCom pullback on Abbott news a buying opportunity, says Jefferies 03/08/23 Wells Fargo Wells downgrades Edwards Lifesciences with Medtronic gaining share 03/07/23 BofA BofA says buy DexCom on weakness after Abbott's Libre gets pump integration ABT Abbott $97.10 / -1.345 (-1.37%) 01/25/23 Abbott sees FY23 adjusted EPS $4.30-$4.50, consensus $4.40 01/25/23 Abbott reports Q4 adjusted EPS $1.03, consensus 92c 01/24/23 Notable companies reporting before tomorrow's open 01/24/23 Notable companies reporting before tomorrow's open ABT Abbott $97.10 / -1.345 (-1.37%) 01/22/23 Abbott says cooperating with DoJ in baby formula probe, Bloomberg says 01/20/23 DOJ investigating conduct at Abbott infant-formula plant, WSJ reports ABT Abbott $97.10 / -1.345 (-1.37%) 02/22/23 Diabetes management stocks slide on report of tech giant's breakthroughs 02/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/09/23 What You Missed On Wall Street On Thursday 02/09/23 What You Missed On Wall Street This Morning 04/28/23 Abbott Laboratories ABT Abbott $97.10 / -1.345 (-1.37%) 11/28/22 Abbott put volume heavy and directionally bearish 10/07/22 Early notable gainers among liquid option names on October 7th 10/06/22 Abbott call volume above normal and directionally bullish

Hot Stocks	Ionis Pharmaceuticals' IONIS-MAPTRx shows tau reduction efficacy in Alzheimer's » 08:49 03/29/23 03/29 08:49 03/29/23 08:49 IONS Ionis Pharmaceuticals $34.30 / +0.575 (+1.71%) , BIIB Biogen $270.29 / +0.66 (+0.24%) Ionis Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options IONS BIIB IONS Ionis Pharmaceuticals $34.30 / +0.575 (+1.71%) 03/27/23 Ionis Pharmaceuticals announces NEURO-TTRansform study met co-primary endpoints 03/23/23 Ionis says FDA advisors vote in favor of potential tofersen accelerated approval 03/07/23 Ionis Pharmaceuticals: FDA accepts NDA for eplontersen 02/01/23 Ionis Pharmaceuticals: GSK advances bepirovirsen into Phase 3 development BIIB Biogen $270.29 / +0.66 (+0.24%) 03/22/23 Biogen provides update on AdCom meeting on Tofersen for SOD1-ALS 03/22/23 Inozyme appoints Matthew Winton as COO 03/20/23 FDA posts briefing document for advisors' review of Biogen's ALS drug 03/16/23 Biogen receives favorable court ruling on TECFIDERA IONS BIIB IONS Ionis Pharmaceuticals $34.30 / +0.575 (+1.71%) 03/21/23 Bernstein Ionis Pharmaceuticals initiated with an Underperform at Bernstein 02/23/23 SVB Securities Ionis Pharmaceuticals price target lowered to $27 from $34 at SVB Securities 02/23/23 Barclays Ionis Pharmaceuticals price target lowered to $40 from $44 at Barclays 01/19/23 Piper Sandler Ionis Pharmaceuticals price target raised to $62 from $60 at Piper Sandler BIIB Biogen $270.29 / +0.66 (+0.24%) 03/21/23 BofA FDA briefing docs suggest FDA in favor of Biogen's tofersen, says BofA 03/17/23 Stifel Stifel trims Biogen target, but has more confidence lecanemab 'best-in-class' 03/13/23 RBC Capital Biogen price target raised to $350 from $335 at RBC Capital 03/09/23 BofA No ad com suggests positive potential outcome for Sage's zura, says BofA IONS BIIB IONS Ionis Pharmaceuticals $34.30 / +0.575 (+1.71%) 02/22/23 Ionis Pharmaceuticals sees FY23 revenue $575M, consensus $672.18M 02/22/23 Ionis Pharmaceuticals reports Q4 EPS (37c), consensus (92c) 11/09/22 Ionis Pharmaceuticals backs 2022 revenue above $575M, consensus $594.45M 11/09/22 Ionis Pharmaceuticals reports Q3 EPS (33c), consensus (74c) BIIB Biogen $270.29 / +0.66 (+0.24%) 02/15/23 Biogen sees FY23 EPS $15.00-$16.00, consensus $15.72 02/15/23 Biogen reports Q4 EPS $4.05, consensus $3.48 02/14/23 Notable companies reporting before tomorrow's open 02/14/23 Notable companies reporting before tomorrow's open BIIB BIIB Biogen $270.29 / +0.66 (+0.24%) 03/13/23 VA to widely cover new Alzheimer's treatment from Eisai and Biogen, STAT says 01/11/23 FDA Commissioner defends FDA's approval of Biogen's Aduhelm, WSJ reports 12/23/22 Third trial death tied to Biogen and Eisai Alzheimer's drug, Science reports 11/28/22 Second death linked to Eisai's lecanemab Alzheimer's drug, Science says IONS BIIB IONS Ionis Pharmaceuticals $34.30 / +0.575 (+1.71%) 03/24/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BIIB Biogen $270.29 / +0.66 (+0.24%) 02/15/23 What You Missed On Wall Street On Wednesday 02/15/23 What You Missed On Wall Street This Morning 02/15/23 Fly Intel: Pre-market Movers 01/20/23 Fly Intel: Pre-market Movers 07/06/23 PDUFA Date for Leqembi 08/05/23 PDUFA Date for Zuranolone 12/22/23 PDUFA Date for Eplontersen 05/04/23 Biogen BIIB BIIB Biogen $270.29 / +0.66 (+0.24%) 11/30/22 Early notable gainers among liquid option names on November 30th 11/14/22 Early notable gainers among liquid option names on November 14th 10/13/22 Early notable gainers among liquid option names on October 13th 09/29/22 Unusually active option classes on open September 29th
Recommendations	VF Corp. price target lowered to $24 from $28 at UBS » 08:48 03/29/23 03/29 08:48 03/29/23 08:48 VFC VF Corp. $21.21 / +0.375 (+1.80%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options VFC VF Corp. $21.21 / +0.375 (+1.80%) 02/07/23 VF Corp. expects Vans to be down high single digit percentage range in FY23 02/07/23 VF Corp. sees $225M of annualized savings in fiscal 2024 02/07/23 VF commencing strategic alternatives for Global Packs business 02/07/23 VF Corp. cuts quarterly dividend to 30c from 51c per share VFC VF Corp. $21.21 / +0.375 (+1.80%) 03/20/23 Williams Trading VF Corp. double upgraded to Buy at Williams Trading after management meetings 03/20/23 Baird VF Corp. price target lowered to $24 from $30 at Baird 03/20/23 Williams Trading VF Corp. upgraded to Buy from Sell at Williams Trading 02/10/23 Stifel VF Corp. upgraded to Buy from Hold at Stifel VFC VF Corp. $21.21 / +0.375 (+1.80%) 02/07/23 VF Corp. sees FY24 operating earnings up double-digits 02/07/23 VF Corp. sees FY23 adjusted EPS $2.05-$2.15 vs. prior $2.00-$2.20 02/07/23 VF Corp. reports Q3 adjusted EPS $1.12, consensus 98c 02/07/23 Notable companies reporting after market close VFC VF Corp. $21.21 / +0.375 (+1.80%) 03/20/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/10/23 What You Missed On Wall Street On Friday 02/10/23 What You Missed On Wall Street This Morning 02/10/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations VFC VF Corp. $21.21 / +0.375 (+1.80%) 03/15/23 V F Corp call volume above normal and directionally bullish 03/10/23 V F Corp call volume above normal and directionally bullish 03/01/23 V F Corp call volume above normal and directionally bullish 02/09/23 V F Corp put volume heavy and directionally bearish
Hot Stocks	Conduent implements child support payment processing system in New Hampshire » 08:48 03/29/23 03/29 08:48 03/29/23 08:48 CNDT Conduent $3.15 / -0.02 (-0.63%) Conduent announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CNDT Conduent $3.15 / -0.02 (-0.63%) 03/06/23 Conduent to showcase fare collection solutions at Transport Ticketing Global 02/23/23 Conduent selected by Virgin Atlantic to support customer experience 02/14/23 Conduent selected by NMHSD to deliver Medicaid Management Information System 02/07/23 Conduent, Genesys partner to enhance customer experience solution CNDT Conduent $3.15 / -0.02 (-0.63%) 05/31/22 Gordon Haskett Conduent 'overdue to be sold,' says Gordon Haskett CNDT Conduent $3.15 / -0.02 (-0.63%) 11/01/22 Conduent sees 2022 revenue $3.85B-$3.95B, consensus $3.91B 11/01/22 Conduent reports Q3 adjusted EPS 9c, consensus 8c
Recommendations	Under Armour price target lowered to $15 from $16 at UBS » 08:48 03/29/23 03/29 08:48 03/29/23 08:48 UAA Under Armour / + , UA Under Armour $8.04 / +0.03 (+0.37%) UBS lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options UAA UA UAA Under Armour / + 02/08/23 Under Armour expects macroeconomic backdrop to remain uneven in 2023 12/21/22 Under Armour names Stephanie Linnartz as CEO 12/21/22 Marriott president Stephanie Linnartz leaving to become CEO of Under Armour 11/18/22 Adtalem Global Education appoints Blake Simpson as CCO UA Under Armour $8.04 / +0.03 (+0.37%) 02/08/23 Under Armour expects macroeconomic backdrop to remain uneven in 2023 12/21/22 Under Armour names Stephanie Linnartz as CEO 12/21/22 Marriott president Stephanie Linnartz leaving to become CEO of Under Armour 11/18/22 Adtalem Global Education appoints Blake Simpson as CCO UAA UA UAA Under Armour / + 03/21/23 Evercore ISI Foot Locker upgraded to Outperform from In Line at Evercore ISI 03/16/23 Williams Trading Under Armour upgraded to Buy from Hold at Williams Trading 03/16/23 Redburn Under Armour initiated with a Buy at Redburn 03/13/23 JPMorgan Under Armour downgraded to Neutral from Overweight at JPMorgan UA Under Armour $8.04 / +0.03 (+0.37%) 03/21/23 Evercore ISI Foot Locker upgraded to Outperform from In Line at Evercore ISI 03/16/23 Williams Trading Under Armour upgraded to Buy from Hold at Williams Trading 03/16/23 Redburn Under Armour initiated with a Buy at Redburn 03/13/23 JPMorgan Under Armour downgraded to Neutral from Overweight at JPMorgan UAA UA UAA Under Armour / + 02/08/23 Under Armour raises FY23 adjusted EPS view to 52c-56c from 44c-48c 02/08/23 Under Armour reports Q3 adjusted EPS 16c, consensus 9c 02/07/23 Notable companies reporting before tomorrow's open 02/07/23 Notable companies reporting before tomorrow's open UA Under Armour $8.04 / +0.03 (+0.37%) 02/08/23 Under Armour raises FY23 adjusted EPS view to 52c-56c from 44c-48c 02/08/23 Under Armour reports Q3 adjusted EPS 16c, consensus 9c 02/07/23 Notable companies reporting before tomorrow's open 02/07/23 Notable companies reporting before tomorrow's open UAA UA UAA Under Armour / + 03/24/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/16/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/13/23 What You Missed On Wall Street On Monday 03/13/23 What You Missed On Wall Street This Morning UA Under Armour $8.04 / +0.03 (+0.37%) 03/24/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/16/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/13/23 What You Missed On Wall Street On Monday 03/13/23 What You Missed On Wall Street This Morning 05/19/23 Under Armour UAA UAA Under Armour / + 10/31/22 Under Armour Class A call volume above normal and directionally bullish 10/10/22 Under Armour Class A call volume above normal and directionally bullish
Initiation	Intuitive Surgical assumed with a Neutral at UBS » 08:48 03/29/23 03/29 08:48 03/29/23 08:48 ISRG Intuitive Surgical $249.55 / -2.74 (-1.09%) UBS analyst Danielle… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ISRG Intuitive Surgical $249.55 / -2.74 (-1.09%) 01/24/23 Intuitive Surgical sees FY23 procedure growth up 12%-16% 10/25/22 Intuitive Surgical reports $1B accelerated share repurchase agreement 10/19/22 Intuitive Surgical receives Royal College of Surgeons of England accreditation 10/18/22 Intuitive Surgical raises FY22 procedure growth view to 17%-18% from 14%-16.5% ISRG Intuitive Surgical $249.55 / -2.74 (-1.09%) 03/28/23 UBS Intuitive Surgical initiated with a Neutral at UBS 03/24/23 Evercore ISI Evercore says Intuitive Surgical outperformance tied to new system speculation 03/23/23 William Blair William Blair starts Intuitive Surgical at Outperform on favorable risk/reward 03/23/23 William Blair Intuitive Surgical initiated with an Outperform at William Blair ISRG Intuitive Surgical $249.55 / -2.74 (-1.09%) 01/24/23 Intuitive Surgical reports Q4 EPS $1.23, consensus $1.25 01/24/23 Notable companies reporting after market close 01/11/23 Intuitive Surgical sees Q4 revenue $1.66B, consensus $1.68B 10/18/22 Intuitive Surgical reports Q3 EPS $1.19, consensus $1.12 ISRG Intuitive Surgical $249.55 / -2.74 (-1.09%) 03/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/25/23 What You Missed On Wall Street On Wednesday 01/25/23 What You Missed On Wall Street This Morning 01/25/23 Fly Intel: Pre-market Movers 04/18/23 Intuitive Surgical - ISRG 04/27/23 Intuitive Surgical Inc ISRG Intuitive Surgical $249.55 / -2.74 (-1.09%) 03/24/23 Early notable gainers among liquid option names on March 24th 01/24/23 Intuitive Surgical options imply 4.8% move in share price post-earnings 10/19/22 Early notable gainers among liquid option names on October 19th 10/18/22 Intuitive Surgical options imply 6.0% move in share price post-earnings
Recommendations	Tapestry price target lowered to $42 from $44 at UBS » 08:48 03/29/23 03/29 08:48 03/29/23 08:48 TPR Tapestry $41.73 / +0.99 (+2.43%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TPR Tapestry $41.73 / +0.99 (+2.43%) 12/04/22 Fly Intel: Top five weekend stock stories TPR Tapestry $41.73 / +0.99 (+2.43%) 02/10/23 Morgan Stanley Tapestry assumed with an Equal Weight at Morgan Stanley 02/10/23 Baird Tapestry price target raised to $52 from $45 at Baird 01/23/23 Barclays Capri Holdings price target raised to $72 from $56 at Barclays 01/23/23 Barclays Tapestry downgraded to Equal Weight from Overweight at Barclays TPR Tapestry $41.73 / +0.99 (+2.43%) 02/09/23 Tapestry raises FY23 EPS view to $3.70-$3.75 from $3.60-$3.70, consensus $3.65 02/09/23 Tapestry reports Q2 EPS $1.36, consensus $1.27 02/08/23 Notable companies reporting before tomorrow's open 02/08/23 Notable companies reporting before tomorrow's open TPR Tapestry $41.73 / +0.99 (+2.43%) 12/03/22 Tapestry, Saia among small-cap stocks set for big gains, Barron's says TPR Tapestry $41.73 / +0.99 (+2.43%) 02/09/23 What You Missed On Wall Street On Thursday 02/09/23 What You Missed On Wall Street This Morning 02/09/23 Fly Intel: Pre-market Movers 01/23/23 What You Missed On Wall Street On Monday TPR Tapestry $41.73 / +0.99 (+2.43%) 03/09/23 Tapestry put volume heavy and directionally bearish 11/04/22 Unusually active option classes on open November 4th
Recommendations	Skechers price target lowered to $60 from $69 at UBS » 08:47 03/29/23 03/29 08:47 03/29/23 08:47 SKX Skechers $45.78 / +1.155 (+2.59%) UBS lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options SKX Skechers $45.78 / +1.155 (+2.59%) 03/08/23 Skechers and Martha Stewart team on First footwear collaboration 10/26/22 Skechers issues statement on unauthorized visit by Kanye West 10/26/22 Skechers falls -8.9% 10/25/22 Skechers falls 11% to $32.00 after Q4 guidance misses estimates SKX Skechers $45.78 / +1.155 (+2.59%) 02/03/23 UBS Skechers price target raised to $69 from $63 at UBS 02/03/23 Cowen Skechers price target lowered to $62 from $65 at Cowen 01/23/23 Cowen Skechers upgraded to Outperform at Cowen on momentum and margin recovery 01/23/23 Deutsche Bank Skechers price target raised to $54 from $43 at Deutsche Bank SKX Skechers $45.78 / +1.155 (+2.59%) 02/02/23 Skechers sees FY23 EPS $2.80-$3.00, consensus $3.04 02/02/23 Skechers sees Q1 EPS 55c-60c, consensus 84c 02/02/23 Skechers reports Q4 adjusted EPS 48c, consensus 36c 02/02/23 Notable companies reporting after market close SKX Skechers $45.78 / +1.155 (+2.59%) 02/02/23 Fly Intel: After-Hours Movers 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/18/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/29/22 What You Missed On Wall Street On Thursday SKX Skechers $45.78 / +1.155 (+2.59%) 10/26/22 Largest borrow rate increases among liquid names 10/25/22 Skechers options imply 9.4% move in share price post-earnings
Recommendations	Ralph Lauren price target lowered to $154 from $157 at UBS » 08:47 03/29/23 03/29 08:47 03/29/23 08:47 RL Ralph Lauren $115.54 / +2.77 (+2.46%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options RL Ralph Lauren $115.54 / +2.77 (+2.46%) 02/09/23 Ralph Lauren CEO: Macro environment 'choppy,' consumer 'resilient' 01/25/23 Ralph Lauren CEO sells $2.31M in common stock 01/19/23 Ralph Lauren CEO sells $2.22M in common stock 11/10/22 Ralph Lauren sees gross margin expansion in 2H RL Ralph Lauren $115.54 / +2.77 (+2.46%) 02/13/23 BofA Ralph Lauren upgraded to Buy from Neutral at BofA 02/10/23 Deutsche Bank Ralph Lauren price target raised to $119 from $114 at Deutsche Bank 02/10/23 Cowen Ralph Lauren price target raised to $151 from $148 at Cowen 02/10/23 Credit Suisse Ralph Lauren price target raised to $135 from $115 at Credit Suisse RL Ralph Lauren $115.54 / +2.77 (+2.46%) 02/09/23 Ralph Lauren backs FY23 revenue view up 13.5%-14%, consensus $6.28B 02/09/23 Ralph Lauren sees Q4 revenue up mid- to high-single digits, consensus $1.45B 02/09/23 Ralph Lauren reports Q3 EPS $3.20, consensus $2.92 02/08/23 Notable companies reporting before tomorrow's open RL Ralph Lauren $115.54 / +2.77 (+2.46%) 02/18/23 Buy/Sell: Wall Street's top 10 stock calls this week 02/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/09/23 Fly Intel: Pre-market Movers 01/27/23 What You Missed On Wall Street On Friday RL Ralph Lauren $115.54 / +2.77 (+2.46%) 03/28/23 Early notable gainers among liquid option names on March 28th 11/11/22 Early notable gainers among liquid option names on November 11th
Recommendations	Children's Place price target lowered to $40 from $45 at UBS » 08:47 03/29/23 03/29 08:47 03/29/23 08:47 PLCE Children's Place $38.28 / +0.25 (+0.66%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly PLCE Children's Place $38.28 / +0.25 (+0.66%) 02/06/23 Children's Place falls 10% to $42.08 after lowering Q4 outlook 11/17/22 Children's Place expects to close 40-50 stores this year 10/24/22 Children's Place appoints Sheamus Toal as CFO 10/17/22 Ollie's Bargain Outlet appoints Rob Helm as CFO PLCE Children's Place $38.28 / +0.25 (+0.66%) 02/07/23 Telsey Advisory Children's Place downgraded to Market Perform from Outperform at Telsey 11/18/22 UBS Children's Place price target lowered to $41 from $43 at UBS 08/18/22 B. Riley Children's Place price target lowered to $64 from $69 at B. Riley 08/16/22 B. Riley Children's Place price target lowered to $69 from $84 at B. Riley PLCE Children's Place $38.28 / +0.25 (+0.66%) 03/16/23 Children's Place sees FY23 adjusted EPS $2.50-$3.00, consensus $3.35 03/16/23 Children's Place sees Q1 adjusted EPS ($1.60)-($1.90), consensus ($1.21) 03/16/23 Children's Place reports Q4 EPS ($4.10), consensus ($4.09) 02/06/23 Children's Place lowers Q4 adjusted EPS view to ($4.02)-($4.41) from 50c-75c PLCE Children's Place $38.28 / +0.25 (+0.66%) 03/16/23 What You Missed On Wall Street On Thursday 03/16/23 What You Missed On Wall Street This Morning 02/06/23 What You Missed On Wall Street On Monday 02/06/23 What You Missed On Wall Street This Morning
Initiation	Medtronic assumed with a Sell at UBS » 08:47 03/29/23 03/29 08:47 03/29/23 08:47 MDT Medtronic / + UBS assumed coverage of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MDT Medtronic / + 03/21/23 Medtronic, Nvidia collaborate to build AI platform for medical devices 03/15/23 Medtronic receives CE Mark for the Affera Mapping and Ablation System 03/06/23 Medtronic's PulseSelect PFA System exceeds safety performance goal in trial 02/24/23 Medtronic announces one-year data from ADAPT study of MiniMed 780G system MDT Medtronic / + 03/28/23 UBS Medtronic assumed at Sell from Buy at UBS 03/28/23 UBS Medtronic downgraded to Sell from Buy at UBS 03/08/23 Wells Fargo Wells downgrades Edwards Lifesciences with Medtronic gaining share 02/22/23 Deutsche Bank Medtronic price target raised to $87 from $80 at Deutsche Bank MDT Medtronic / + 02/21/23 Medtronic sees Q4 EPS $1.55-$1.57, consensus $1.58 02/21/23 Medtronic narrows FY23 EPS view to $5.28-$5.30 from $5.25-$5.30 02/21/23 Medtronic reports Q3 EPS $1.30, consensus $1.27 11/22/22 Medtronic sees Q3 adjusted EPS $1.25-$1.27, consensus $1.40 MDT Medtronic / + 02/22/23 Apple hits breakthroughs in glucose monitoring project, Bloomberg reports 02/08/23 Apple names Medtronic's Surface as Chief People Officer, Bloomberg says 12/17/22 Amazon, Google among Barron's 10 favorite stocks for 2023 12/15/22 GE among companies studying Medtronic businesses, Bloomberg reports MDT Medtronic / + 03/08/23 What You Missed On Wall Street On Wednesday 03/08/23 What You Missed On Wall Street This Morning 02/22/23 Diabetes management stocks slide on report of tech giant's breakthroughs 02/21/23 What You Missed On Wall Street On Tuesday MDT Medtronic / + 02/09/23 Medtronic put volume heavy and directionally bearish 01/09/23 Medtronic put volume heavy and directionally bearish 11/21/22 Early notable gainers among liquid option names on November 21st 11/04/22 Medtronic call volume above normal and directionally bullish

Recommendations	Kontoor Brands price target lowered to $65 from $66 at UBS » 08:47 03/29/23 03/29 08:47 03/29/23 08:47 KTB Kontoor Brands $47.88 / +0.7 (+1.48%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events KTB Kontoor Brands $47.88 / +0.7 (+1.48%) 02/28/23 Kontoor Brands rises 14.8% 02/28/23 Kontoor Brands rises 12.6% 10/24/22 Kontoor Brands raises quarterly dividend by 4% to 48c per share 10/03/22 Kontoor Brands names Ezio Garciamendez as Chief Supply Chain Officer KTB Kontoor Brands $47.88 / +0.7 (+1.48%) 03/08/23 UBS Kontoor Brands price target raised to $66 from $54 at UBS 03/07/23 Barclays Kontoor Brands price target raised to $51 from $37 at Barclays 03/01/23 Wells Fargo Kontoor Brands price target raised to $59 from $48 at Wells Fargo 02/28/23 Stifel Kontoor Brands upgraded to Buy at Stifel amid brand momentum, share gains KTB Kontoor Brands $47.88 / +0.7 (+1.48%) 02/28/23 Kontoor Brands sees FY23 EPS $4.55-$4.75, consensus $4.36 02/28/23 Kontoor Brands reports Q4 adjusted EPS 88c, consensus 67c 11/03/22 Kontoor Brands cuts FY22 adjusted EPS view to $4.35-$4.40 from $4.40-$4.50 11/03/22 Kontoor Brands reports Q3 adjusted EPS $1.11, consensus 88c KTB Kontoor Brands $47.88 / +0.7 (+1.48%) 02/28/23 What You Missed On Wall Street On Tuesday 02/28/23 What You Missed On Wall Street This Morning 04/20/23 Kontoor Brands, Inc.
Recommendations	nCino price target lowered to $33 from $35 at Needham » 08:46 03/29/23 03/29 08:46 03/29/23 08:46 NCNO nCino $22.35 / -0.01 (-0.04%) Needham analyst Mayank… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options NCNO nCino $22.35 / -0.01 (-0.04%) 02/28/23 nCino selected by JFG to modernize multiple lines of business 02/22/23 nCino's SimpleNexus announces Avidia Bank implemented Nexus Closing 02/13/23 nCino says DOJ investigation closed, no fines or penalties imposed 02/07/23 nCino expands nCino IQ offerings through partnership with rich data company NCNO nCino $22.35 / -0.01 (-0.04%) 07:46 Today Truist nCino price target lowered to $40 from $45 at Truist 07:30 Today BofA nCino price target lowered to $30 from $32 at BofA 05:29 Today Barclays nCino price target lowered to $26 from $35 at Barclays 03/24/23 Morgan Stanley nCino price target lowered to $27 from $35 at Morgan Stanley NCNO nCino $22.35 / -0.01 (-0.04%) 03/28/23 nCino reports Q4 EPS 4c, consensus (5c) 01/19/23 nCino backs FY23 EPS view of (15c)-(17c), consensus (16c) 01/19/23 nCino backs Q4 EPS view of (4c)-(5c), consensus (5c) 11/30/22 nCino raises FY23 EPS view to (17c)-(15c) from (19c)-(17c), consensus (17c) NCNO nCino $22.35 / -0.01 (-0.04%) 03/28/23 Fly Intel: After-Hours Movers 03/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/14/23 What You Missed On Wall Street On Tuesday 03/14/23 What You Missed On Wall Street This Morning NCNO nCino $22.35 / -0.01 (-0.04%) 11/30/22 nCino options imply 9.0% move in share price post-earnings
Recommendations	Kohl's price target lowered to $16 from $18 at UBS » 08:46 03/29/23 03/29 08:46 03/29/23 08:46 KSS Kohl's $21.77 / +0.09 (+0.42%) UBS lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KSS Kohl's $21.77 / +0.09 (+0.42%) 03/22/23 Kohl's announces locations of 250 new Sephora at Kohl's opening this year 02/28/23 Kohl's appoints Dave Alves COO 02/09/23 Kohl's names Nick Jones Chief Merchandising and Digital Officer 02/02/23 Kohl's names Tom Kingsbury as CEO KSS Kohl's $21.77 / +0.09 (+0.42%) 03/02/23 Deutsche Bank Kohl's price target lowered to $31 from $34 at Deutsche Bank 03/02/23 Citi Kohl's price target lowered to $26 from $29 at Citi 03/02/23 Morgan Stanley Kohl's assumed with an Underweight at Morgan Stanley 03/01/23 Credit Suisse Credit Suisse lowers Kohl's price target to $27 following quarterly results KSS Kohl's $21.77 / +0.09 (+0.42%) 03/01/23 Kohl's sees FY23 EPS $2.10-$2.70, consensus $2.99 03/01/23 Kohl's reports Q4 adjusted EPS ($2.49), consensus 98c 02/28/23 Notable companies reporting before tomorrow's open 02/28/23 Notable companies reporting before tomorrow's open KSS Kohl's $21.77 / +0.09 (+0.42%) 01/25/23 Interim Kohl's CEO Kingsbury in late-stage talks to be permanent CEO, NYT says 01/10/23 Franchise Group could go private or may bid to buy Conn's, WSJ reports 10/12/22 Macellum urges Kohl's to make board changes, WSJ reports KSS Kohl's $21.77 / +0.09 (+0.42%) 03/01/23 What You Missed On Wall Street On Wednesday 03/01/23 What You Missed On Wall Street This Morning 03/01/23 Fly Intel: Pre-market Movers 01/30/23 What You Missed On Wall Street On Monday 05/10/23 Kohl's Corporation KSS Kohl's $21.77 / +0.09 (+0.42%) 03/10/23 Kohl's call volume above normal and directionally bullish 03/01/23 Unusually active option classes on open March 1st 01/30/23 Kohl's put volume heavy and directionally bearish 01/27/23 Unusually active option classes on open January 27th
Earnings	Cintas reports Q3 EPS $3.14, consensus $3.04 » 08:46 03/29/23 03/29 08:46 03/29/23 08:46 CTAS Cintas $443.89 / +3.48 (+0.79%) Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CTAS Cintas $443.89 / +3.48 (+0.79%) 12/16/22 Cintas launches electric vehicle pilot program 11/15/22 Cintas expands cleanroom footprint with new facility in New York CTAS Cintas $443.89 / +3.48 (+0.79%) 12/22/22 Wells Fargo Cintas price target raised to $450 from $393 at Wells Fargo 12/22/22 Deutsche Bank Cintas price target raised to $507 from $490 at Deutsche Bank 12/22/22 Baird Cintas price target raised to $500 from $475 at Baird 12/22/22 Morgan Stanley Cintas price target raised to $401 from $373 at Morgan Stanley CTAS Cintas $443.89 / +3.48 (+0.79%) 08:41 Today Cintas raises FY23 EPS view to $12.70-$12.90 from $12.50-$12.80 08:37 Today Cintas reports Q4 EPS $3.14, consensus $3.04 12/21/22 Cintas raises FY23 EPS view to $12.50-$12.80 from $12.30-$12.65 12/21/22 Cintas reports Q2 EPS $3.12, consensus $3.03 CTAS Cintas $443.89 / +3.48 (+0.79%) 12/21/22 What You Missed On Wall Street On Wednesday 12/21/22 What You Missed On Wall Street This Morning 10:00 Today Cintas - CTAS
Recommendations	Hanesbrands price target lowered to $5 from $7 at UBS » 08:46 03/29/23 03/29 08:46 03/29/23 08:46 HBI Hanesbrands $5.11 / +0.1 (+2.00%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options HBI Hanesbrands $5.11 / +0.1 (+2.00%) 03/20/23 S&P announces changes to S&P 400, 600 indices at open on 3/20 03/07/23 Hanesbrands and UCLA announce multi-year apparel agreement, no terms 03/03/23 S&P announces changes to S&P 400, 600 indices at open on 3/20 02/02/23 Hanesbrands falls -22.6% HBI Hanesbrands $5.11 / +0.1 (+2.00%) 02/03/23 Citi Hanesbrands price target lowered to $7 from $8 at Citi 01/13/23 Barclays Hanesbrands price target raised to $8 from $7 at Barclays 11/09/22 Credit Suisse Hanesbrands downgraded to Neutral from Outperform at Credit Suisse 11/06/22 Citi Hanesbrands price target lowered to $7 from $11 at Citi HBI Hanesbrands $5.11 / +0.1 (+2.00%) 02/02/23 Hanesbrands sees FY23 EPS 31c-42c, consensus 94c 02/02/23 Hanesbrands sees Q1 EPS (4c)- (9c) , consensus 14c 02/02/23 Hanesbrands reports Q4 EPS 7c, consensus 7c 01/12/23 Hanesbrands sees Q4 sales 'slightly above' top end of outlook range HBI Hanesbrands $5.11 / +0.1 (+2.00%) 02/02/23 What You Missed On Wall Street On Thursday 02/02/23 What You Missed On Wall Street This Morning 01/13/23 What You Missed On Wall Street On Friday 01/13/23 What You Missed On Wall Street This Morning 04/24/23 Hanesbrands Inc. HBI Hanesbrands $5.11 / +0.1 (+2.00%) 02/24/23 HanesBrands call volume above normal and directionally bullish 02/22/23 HanesBrands put volume heavy and directionally bearish 02/03/23 HanesBrands call volume above normal and directionally bullish 01/24/23 HanesBrands put volume heavy and directionally bearish

Events

Earnings calls, analyst events, roadshows and more

RDW
Today at 09:00

Redwire - RDW Conference Calls
BOSC
Today at 09:00

BOS Better Online Solutions - BOSC Conference Calls
IBEX
Today at 09:00

Ibex - IBEX Conference Calls
UNF
Today at 09:00

UniFirst - UNF Conference Calls
CLH
Today at 09:00

Clean Harbors Firm Sponsored Meetings

Virtual Meeting
PAYX
Today at 09:30

Paychex - PAYX Conference Calls
RMR
Today at 09:30

The RMR Group Inc. Firm Sponsored Meetings
Today at 10:00

Joint Committee Meeting Government Event

Teleconference
Today at 10:00

Pending Home Sales Index M/M: February 2023 Government Event
Today at 10:00

Pending Home Sales Index: February 2023 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	YGF X YGF YanGuFang IPO Managers: EF Hutton Priced at: $4.00 2M Shares ZJYL X ZJYL Jin Medical IPO Managers: Prime Number Priced at: $8.00 1M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	BMEA X BMEA Biomea Fusion Secondary Managers: JPMorgan & Citi, Oppenheimer, Barclays $30.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	SYT X SYT Syla Technologies IPO Managers: Boustead $8.00 1.875M Shares
Fri	No deals

View All Syndicate Announcements »

Asana reports Q3 EPS (26c), consensus (32c)

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access